Remdesivir GS-5734 CAS 1809249-37-3 COVID-19 API High Quality

Description:

Nomen chemicum: Remdesivir (GS-5734)

CAS: 1809249-37-3

Aspectus: Alba ad Off-White solidus pulveris

Intenta: 98.0%~ 102.0%

Remdesivir ad curationem COVID-19

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Remdesivir
Synonyma GS-5734;2-ethylbutyl((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano -3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninatum
CAS Number 1809249-37-3
CATTUS Number RF-API96
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C27H35N6O8P
M. Pondus 602.58
Density 1.47±0.1 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus White ad Off-White solidus pulveris
Lepidium sativum IR: Imaginum producti effusio ultrarubrum consentaneum esse debet cum substantiae relationis
Lepidium sativum B * HPLC retentionis tempus similis referat substantiam
Imprimis Rotationes -19.0° ~ -22.0°
Solubilitas Solunle in Methanol, Parce Solubile in Ethanol, Paulo solutum in Acetonitrile, In aqua fere Insolubile.
Substantiae cognatae
Omnis immunditia ≤0.10%
Totalis immunditias ≤1.0%
RD-3.1 ≤0.10%
RD-C ≤0.10%
RD-D ≤0.10%
RD-E ≤0.10%
RP-Isomer ≤0.10%
Nitrophenol ≤0.10%
RELICTUM Solvents
Methanolum Dichloride ≤6000ppm
Acetone ≤5000ppm
Isopropyl Sin ≤5000ppm
Acetonitrile ≤410ppm
Dichloromethane ≤600ppm
Methyl tert Butyl Ether ≤5000ppm
Ethyl Acetate ≤5000ppm
Tetrahydrofuran ≤720ppm
n-Heptane ≤5000ppm
Assay 98.0% ~ 102.0% (Ratio in exaruit basis)
Summa Aerobic Comites
Aerobic Bacteria ≤100cfu/g*
Fermentum et Molde ≤10cfu/g*
E. Coil Negative
Bacterial Endotoxin ≤1.0EU
Metalla gravis ≤20ppm
Test Standard Enterprise Standard
Consuetudinem API, COVID-19

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

Remdesivir (CAS 1809249-37-3), sub noto nomine Veklury venditum, est medicamentum latum-spectrum antivirale a comitatu Scientiarum Gilead biopharmaceutico elaboratum.Datur per iniectionem in venam.Per COVID-19 pandemicum, remdesivir probatus est vel auctoritate usus subitis ad COVID-19 tractandum in regionibus circiter 50.Renovatae normae a Mundi Salus Organizatio mense Novembri 2020 includunt commendationem conditionalem contra usum Remdesiviri ad tractandum de COVID-19.Remdesivir principio hepatitis C tractandi elaboravit, et postea de morbis virus virus et Marburg infectio virium Ebola quaesitum est priusquam investigaretur ut curatio post-infectio pro COVID-19.Frequentissimum latus effectus in voluntariis sanis elevatur gradus sanguinis enzymes iecoris (signum problematum iecoris).Frequentissima pars effectuum hominum cum covid-19 nausea est.Effectus latus includere potest iecoris inflammationem et infusionem reactionem relatas cum nausea, pressura sanguinis humilis, et sudore.Remdesivir prodrug intendit ad partum intracellulare GS-441524 permittere monophosphatum et subsequentem biotransformationem in triphosphatum GS-441524, analogum ribonucleotide inhibitoris RNA polymerasi.

Epistulam tuam hic scribe et mitte nobis